Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMEPRAZOLE Cause Hyperammonaemic encephalopathy? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hyperammonaemic encephalopathy have been filed in association with OMEPRAZOLE (omeprazole sodium bicarbonate). This represents 0.0% of all adverse event reports for OMEPRAZOLE.

11
Reports of Hyperammonaemic encephalopathy with OMEPRAZOLE
0.0%
of all OMEPRAZOLE reports
0
Deaths
11
Hospitalizations

How Dangerous Is Hyperammonaemic encephalopathy From OMEPRAZOLE?

Of the 11 reports, 11 (100.0%) required hospitalization.

Is Hyperammonaemic encephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMEPRAZOLE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does OMEPRAZOLE Cause?

Chronic kidney disease (35,759) Acute kidney injury (19,260) Renal failure (14,721) End stage renal disease (10,356) Renal injury (9,482) Tubulointerstitial nephritis (4,809) Drug ineffective (4,355) Gastrooesophageal reflux disease (3,929) Pain (3,602) Nephrogenic anaemia (2,873)

What Other Drugs Cause Hyperammonaemic encephalopathy?

VALPROIC ACID (455) FLUOROURACIL (156) VALPROATE (120) DIVALPROEX (119) OXALIPLATIN (107) TOPIRAMATE (101) RISPERIDONE (96) QUETIAPINE (91) LEVETIRACETAM (71) LEUCOVORIN (62)

Which OMEPRAZOLE Alternatives Have Lower Hyperammonaemic encephalopathy Risk?

OMEPRAZOLE vs OMEPRAZOLE\SODIUM BICARBONATE OMEPRAZOLE vs OMNIPAQUE OMEPRAZOLE vs OMNISCAN OMEPRAZOLE vs ONABOTULINUMTOXINA OMEPRAZOLE vs ONASEMNOGENE ABEPARVOVEC

Related Pages

OMEPRAZOLE Full Profile All Hyperammonaemic encephalopathy Reports All Drugs Causing Hyperammonaemic encephalopathy OMEPRAZOLE Demographics